These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25652731)

  • 21. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of co-nanoprecipitation of organic actives and block copolymers in a microfluidic environment.
    Capretto L; Cheng W; Carugo D; Katsamenis OL; Hill M; Zhang X
    Nanotechnology; 2012 Sep; 23(37):375602. PubMed ID: 22922560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of biodegradable nanoparticles of tri-block PLA-PEG-PLA copolymer and determination of factors controlling the particle size using artificial neural network.
    Asadi H; Rostamizadeh K; Salari D; Hamidi M
    J Microencapsul; 2011; 28(5):406-16. PubMed ID: 21736525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants.
    Zhang JY; Shen ZG; Zhong J; Hu TT; Chen JF; Ma ZQ; Yun J
    Int J Pharm; 2006 Oct; 323(1-2):153-60. PubMed ID: 16828244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of processing parameters on particle size of ultrasound prepared chitosan nanoparticles: an Artificial Neural Networks Study.
    Esmaeilzadeh-Gharedaghi E; Faramarzi MA; Amini MA; Rouholamini Najafabadi A; Rezayat SM; Amani A
    Pharm Dev Technol; 2012; 17(5):638-47. PubMed ID: 22681416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aerosol flow reactor method for synthesis of drug nanoparticles.
    Eerikäinen H; Watanabe W; Kauppinen EI; Ahonen PP
    Eur J Pharm Biopharm; 2003 May; 55(3):357-60. PubMed ID: 12754012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic investigation of the cavi-precipitation process for the production of ibuprofen nanocrystals.
    Sinha B; Müller RH; Möschwitzer JP
    Int J Pharm; 2013 Dec; 458(2):315-23. PubMed ID: 24148667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles.
    Bilati U; Allémann E; Doelker E
    Eur J Pharm Sci; 2005 Jan; 24(1):67-75. PubMed ID: 15626579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology.
    Li Y; Abbaspour MR; Grootendorst PV; Rauth AM; Wu XY
    Eur J Pharm Biopharm; 2015 Aug; 94():170-9. PubMed ID: 25986587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Processing/formulation parameters determining dispersity of chitosan particles: an ANNs study.
    Esmaeilzadeh-Gharehdaghi E; Faramarzi MA; Amini MA; Moazeni E; Amani A
    J Microencapsul; 2014; 31(1):77-85. PubMed ID: 23795904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nanoprecipitation.
    Legrand P; Lesieur S; Bochot A; Gref R; Raatjes W; Barratt G; Vauthier C
    Int J Pharm; 2007 Nov; 344(1-2):33-43. PubMed ID: 17616282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation.
    Dong Y; Ng WK; Shen S; Kim S; Tan RB
    Int J Pharm; 2009 Jun; 375(1-2):84-8. PubMed ID: 19481693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization.
    Matteucci ME; Hotze MA; Johnston KP; Williams RO
    Langmuir; 2006 Oct; 22(21):8951-9. PubMed ID: 17014140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of an artificial neural network as a PAT tool for the prediction of temperature distribution within a pharmaceutical fluidized bed granulator.
    Korteby Y; Mahdi Y; Azizou A; Daoud K; Regdon G
    Eur J Pharm Sci; 2016 Jun; 88():219-32. PubMed ID: 26993961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(vinyl benzoate) nanoparticles for molecular delivery: Studies on their preparation and in vitro properties.
    Labruère R; Sicard R; Cormier R; Turos E; West L
    J Control Release; 2010 Dec; 148(2):234-40. PubMed ID: 20728487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Particle shape effects on subvisible particle sizing measurements.
    Cavicchi RE; Carrier MJ; Cohen JB; Boger S; Montgomery CB; Hu Z; Ripple DC
    J Pharm Sci; 2015 Mar; 104(3):971-87. PubMed ID: 25446188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled nanoparticle formation by diffusion limited coalescence.
    Stepanyan R; Lebouille JG; Slot JJ; Tuinier R; Stuart MA
    Phys Rev Lett; 2012 Sep; 109(13):138301. PubMed ID: 23030126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental design for the optimization of lipid nanoparticles.
    Zhang J; Fan Y; Smith E
    J Pharm Sci; 2009 May; 98(5):1813-9. PubMed ID: 18781636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surfactant free fabrication of polymeric nanoparticles by combined liquid-liquid phase separation and solvent/nonsolvent mixing technology.
    Xiong JY; Liu XY; Sawant PD; Chen SB; Chung TS; Pramoda KP
    J Chem Phys; 2004 Dec; 121(24):12626-31. PubMed ID: 15606287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxicity of chitosan/streptokinase nanoparticles as a function of size: An artificial neural networks study.
    Baharifar H; Amani A
    Nanomedicine; 2016 Jan; 12(1):171-80. PubMed ID: 26409193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.